Distributing $800 Billion: An Early Assessment Of Medicare Part D Risk Adjustment
The viability and stability of the Medicare Part D prescription drug program depend on accurate risk-adjusted payments.
Research
The Elusive Connection Between Health Care Spending And Quality
Richard Cooper has shown a positive association between health care quality and "total spending" at the state level, but he does not appear to understand the limitations of this total spending measure
Price Controls And Global Pharmaceutical Progress
This Perspective reviews critically the work on price control impacts by Darius Lakdawalla and colleagues.
Eliminating the Individual Mandate Penalty in California: Harmful but Non-Fatal Changes in Enrollment And Premiums
The federal tax reform act of December 2017 eliminated the penalty for noncompliance with the Affordable Care Act’s (ACA) individual mandate (also known as the shared responsibility requirement) start
Is Spending More Always Wasteful? The Appropriateness of Care and Outcomes Among Colorectal Cancer Patients.
Post-TRIPS Options for Access to Patented Medicines in Developing Nations
This article explores the tension between granting patent protection under the TRIPS Agreements and the availability of medicines at affordable prices to developing countries.
Get smart & reliable public policy insights right in your inbox.